Pfizer Inc (PFE)

PFE (NYSE:Drugs) EQUITY
$28.56
neg -0.47
-1.60%
Today's Range: 28.25 - 28.98 | PFE Avg Daily Volume: 38,979,400
Last Update: 02/08/16 - 3:59 PM EST
Volume: 47,219,322
YTD Performance: -10.07%
Open: $28.68
Previous Close: $29.03
52 Week Range: $28.47 - $36.46
Oustanding Shares: 6,173,001,952
Market Cap: 179,017,056,608
6-Month Chart
TheStreet Ratings Grade for PFE
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 8 8 8
Moderate Buy 0 1 1 1
Hold 3 3 3 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 1
Mean Rec. 1.55 1.54 1.54 1.71
Latest Dividend: 0.30
Latest Dividend Yield: 4.14%
Dividend Ex-Date: 02/03/16
Price Earnings Ratio: 13.18
Price Earnings Comparisons:
PFE Sector Avg. S&P 500
13.18 23.40 30.32
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-14.99% -12.00% 5.53%
GROWTH 12 Mo 3 Yr CAGR
Revenue -3.80 -0.17 -0.06
Net Income -15.20 -0.18 -0.07
EPS -12.70 -0.36 -0.14
Earnings for PFE:
EBITDA 16.70B
Revenue 48.85B
Average Earnings Estimates
Qtr (03/16) Qtr (06/16) FY (12/16) FY (12/17)
Average Estimate $0.54 $0.58 $2.29 $2.57
Number of Analysts 5 3 7 10
High Estimate $0.57 $0.59 $2.32 $2.75
Low Estimate $0.53 $0.56 $2.26 $2.34
Prior Year $0.51 $0.56 $2.20 $2.29
Growth Rate (Year over Year) 6.67% 2.98% 4.09% 12.31%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Since the Caribbean biopharm launched its IPO last June, half its market cap seems to have vanished somewhere in the Bermuda Triangle.
This play is a way to buy shares with a $28 average or profit if the stock dips post-earnings.
They view the iPhone giant like just another hardware company, but they aren't considering brand loyalty and "razor blade" revenue.
Figuring out what multiple makes sense is a challenge; but here are some analogies that could work.
Two significant, but subtle forces may threaten the group in the next 12 months.
Consider this your fear gauge survival guide.

Defending the Options Trade Real Money Pro($)

Options are a great way to cut risks, if used wisely.

Columnist Conversations

Kelly Services had been strong this morning in the face of intense broad-based selling overall. The stock buil...
$GOLD is sure acting like it's trying to break out. The more it runs, the better odds that the gold miners can...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.